Reading this made me realize HMPV has more vaccine strategies chasing it than I have unread emails, and that’s saying a lot.

Really like how this paper focuses on making biomarker data actually comparable across trials instead of everyone doing their own thing. Standardization like this is what will make aging biomarkers actually trustworthy.

Wild that the future of neurology might be “take your tiny weed drop and do your crossword.” They said, let’s mix cannabis with cognition homework.

Love seeing long‑acting options moving forward for HIV treatment. Weekly oral meds could be a big quality‑of‑life shift, especially for those who struggle with daily adherence.

It's a good reminder that for AI to help real science, we need the boring stuff like validation, de‑duplication, and better metrics just as much as flashy models.

Love seeing new approaches tested for Alzheimer’s, especially ones that seem well‑tolerated. At the same time, this is a small trial so it definitely needs bigger, longer studies

Wow, sounds like pausing to meditate might actually help during a migraine

Ancient method of boosting immunity: ‘really strong homeopathy in the arm’ is killing me. Gonna start calling vaccines ‘spicy water shots'

So my gut bacteria are out there cosplaying as myelin and starting beef with my immune system

This article really called me out. I thought I needed more sleep, but apparently I need to move my body and talk to humans instead of just my AI

A gel that rebuilds enamel is great, but can it also erase the memory of that suction tube noise or is that still phase two?

Seeing an antibody that can both slow tumor growth and cut lung metastases in preclinical TNBC models feels like a real step toward more than “chemo plus hope.”​

Huge news for people with HER2 positive metastatic breast cancer. This combo kept disease controlled for about 3.5 years vs a little over 2 years with standard treatment, but the lung side effect risk around 12 percent means really close monitoring.​